|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Shriners Hospitals for Children |
|---|---|
| Information provided by: | Shriners Hospitals for Children |
| ClinicalTrials.gov Identifier: | NCT00539110 |
Purpose
To examine sleep changes following therapeutic drug interventions designed to promote sleep.
| Condition | Intervention |
|---|---|
|
Sleep Burns |
Drug: eszopiclone Drug: ramelteon |
| Study Type: | Interventional |
| Study Design: | Supportive Care, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment |
Eligibility| Ages Eligible for Study: | 3 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Michele M Gottschlich, PhD, RD, CNSD | 513-872-6298 | mgottschlich@shrinenet.org |
| Contact: Theresa Mayes, BS, RD | 513-872-6043 | tmayes@shrinenet.org |
| United States, Ohio | |
| Shriners Hospital for Children | |
| Cincinnati, Ohio, United States, 45229 | |
| Principal Investigator: | Michele M Gottschlich | Shriners Hospital for Children |
More Information
| Study ID Numbers: | Sleep III |
| Study First Received: | October 2, 2007 |
| Last Updated: | October 3, 2007 |
| ClinicalTrials.gov Identifier: | NCT00539110 History of Changes |
| Health Authority: | United States: Institutional Review Board |